Endexx Corp
OTC:EDXC

Watchlist Manager
Endexx Corp Logo
Endexx Corp
OTC:EDXC
Watchlist
Price: 0.0045 USD 4.65%
Market Cap: 2.6m USD

EV/EBITDA
Enterprise Value to EBITDA

-1.4
Current
-4.3
Median
12.8
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-1.4
=
Enterprise Value
4.2m USD
/
EBITDA
-3.1m USD
Market Cap EV/EBITDA
US
Endexx Corp
OTC:EDXC
2.6m USD -1.4
US
Eli Lilly and Co
NYSE:LLY
766.3B USD 37
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 3 846.3
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 12.5
DK
Novo Nordisk A/S
CSE:NOVO B
2.3T DKK 15.1
CH
Roche Holding AG
SIX:ROG
215.6B CHF 9.8
CH
Novartis AG
SIX:NOVN
190.5B CHF 10.7
UK
AstraZeneca PLC
LSE:AZN
169.5B GBP 131.3
US
Merck & Co Inc
NYSE:MRK
202.1B USD 8.6
IE
Endo International PLC
LSE:0Y5F
163.5B USD 261.3
US
Pfizer Inc
NYSE:PFE
139.2B USD 7.6
EBITDA Growth EV/EBITDA to Growth
US
Endexx Corp
OTC:EDXC
Average EV/EBITDA: 434
Negative Multiple: -1.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.5
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
15.1
13%
1.2
CH
Roche Holding AG
SIX:ROG
9.8
5%
2
CH
Novartis AG
SIX:NOVN
10.7
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
131.3
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.6
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-0.8
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A